Practice of Osmotherapy in Severe SubArachnoid Hemorrhage Patients: Multicenter Observational Study (OSMO-SAH Study)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this prospective multi-center observational study is to learn about the osmotic therapy in severe subarachnoid hemorrhage (SAH). The main question\[s\] it aims to answer are: • whether the two osmotic therapy, 20% mannitol and 10% hypertonic saline(HTS), under the same osmotic equivalent, has similar influence on the outcome of SAH patients? Participants will be given proper treatment according to local expert consensus, including the choice of osmotic medicine. Investigators just record and analyse the data, compare mannitol group and HTS group to see if the outcome of latter is not worse than the former.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• ①age ≥18; ②aneurysmal subarachnoid hemorrhage; ③Hunt-Hess 3-5级

Locations
Other Locations
China
Xuanwu Hospital
RECRUITING
Beijing
Time Frame
Start Date: 2023-07-10
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 124
Related Therapeutic Areas
Sponsors
Leads: Xuanwu Hospital, Beijing

This content was sourced from clinicaltrials.gov

Similar Clinical Trials